A Comprehensive Review of Colchicine: An Ancient Drug with many Therapeutic Potentials. International Journal of Pharmaceutical and Phytopharmacological Research

A Comprehensive Review of Colchicine: An Ancient Drug with many Therapeutic Potentials. International Journal of Pharmaceutical and Phytopharmacological Research

 

Kholoud Elshiwy (1), Ghada Essam El-Din Amin (1,2), Mohamed Nazmy Farres (3), Rasha Samir (3), Mohamed Farouk Allam(1,4*)

1. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

2. Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

3. Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

4. Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Cordoba 14004, Spain.

 

International Journal of Pharmaceutical and Phytopharmacological Research 2024;14(4):17-22.

 

DOI: 10.51847/Hsll58k7kS

 

ABSTRACT

In this study, we aimed to review the literature and formulate a comprehensive understanding of colchicine and its therapeutic potential. Colchicine is one of the oldest treatments which are still used today. Colchicine is an alkaloid agent that has anti-inflammatory and pain-relieving effects. It has been used to treat inflammatory diseases such as gout, familial Mediterranean fever (FMF), and Behcet’s disease. Colchicine's ability to reduce inflammation is linked to its interaction with tubulin, a cytoskeletal structure. Colchicine inhibits neutrophil adhesion, migration, and chemotaxis. Tyrosine phosphorylation, which is crucial for neutrophil activation, is specifically inhibited by colchicine. Additionally, colchicine inhibits neutrophil deformability, which influences neutrophil extravasation. Colchicine inhibits the production of superoxide and the release of interleukin 1β and IL-6. Colchicine decreases the production of inflammasomes that stimulate caspase-1 activation and release of interleukins. Colchicine has gained attention during the COVID-19 pandemic to treat severe COVID-19 cases and to decrease mortality. Colchicine is considered a safe drug with high availability and affordability. Colchicine metabolism is affected by cytochrome P450 (CYP3A4) and P glycoprotein inhibitors, and renal and hepatic function impairment. The most documented adverse effects of colchicine are gastrointestinal symptoms e.g., diarrhea, vomiting, and nausea.

 

Key Words: Colchicine, Mechanism of action, Indications, Review, Ain Shams University.

 

Elshiwy Kh, Amin GEED, Farres MN, Samir R, Allam MF. A Comprehensive Review of Colchicine: An Ancient Drug with Many Therapeutic Potentials. Int J Pharm Phytopharmacol Res. 2024;14(4):17-22.

 

https://eijppr.com/article/a-comprehensive-review-of-colchicine-an-ancient-drug-with-many-therapeutic-potentials-nyokaryx62ld1th?html

Innovative Topical Therapy for Extensive Psoriasis: A New Approach to Treatment

Innovative Topical Therapy for Extensive Psoriasis: A New Approach to Treatment

 

José Miguel Ingelmo Calvo (1), José Ruiz Cobo (2), Mohamed Farouk Allam (3)*

1. Department of Plastic Surgery, Hospital HM Malaga, Malaga, Spain.

2. Distrito Sanitario Costa del Sol, SUAP Torremolinos, Malaga, Spain.

3. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

 

European Journal of Medical and Health Sciences 2024;6(6):6-8.

 

DOI: 10.24018/ejmed.2024.6.6.2200

 

Abstract

We present a case of a patient with extensive psoriasis successfully treated with “Psorisbye,” our newly developed foamy lotion. A 36-year-old male presented to our outpatient clinic with extensive psoriatic lesions affecting the chest, abdomen, back, arms, and forearms. His past medical history was unremarkable. The patient’s primary concern was severe itching associated with the psoriatic lesions. Upon examination, extensive erythrodermic psoriatic lesions were observed, covering approximately 50% of the head and neck, 70% of the trunk, and 70% of both upper and lower limbs. He was advised to use our newly patented lotion, “Psorisbye,” once daily for one month, during which he applied a total of 480 ml over 28 days. No antihistamine was administered during this treatment period. After 28 days of using “Psorisbye,” the patient returned to the clinic, reporting significant improvement in itching and noticeable remission of the red lesions. A comparison of the lesions before and after 28 days of treatment showed a remarkable reduction in his PASI score, improving from 43.7 to 2.8. Our case report demonstrated promising results in treating extensive erythrodermic psoriatic lesions with “Psorisbye.” However, clinical trials with a larger sample size and longer follow-up are essential to further evaluate remission periods and assess any potential adverse effects of applying this innovative topical therapy to large body surface areas.

 

Keywords: Extensive psoriasis, Malaga, Psoriasis Area Severity Index, topical therapy.

 

Calvo JMI, Cobo JR, Allam MF (2024). Innovative Topical Therapy for Extensive Psoriasis: A New Approach to Treatment. European Journal of Medical and Health Sciences, 6(6), 6–8.

 

https://www.ej-med.org/index.php/ejmed/article/view/2200